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Prediction of altered endograft path during
endovascular abdominal aortic aneurysm repair
with the Gore Excluder
David R. Whittaker, MD, Jeff Dwyer, BA, and Mark F. Fillinger, MD, Lebanon, NH
Objective: During endovascular abdominal aortic aneurysm (AAA) repair (EVAR), the rapid deployment of the Gore
Excluder endograft may be associated with anatomic shortening of the endograft path. This shortened path may result in
coverage of the hypogastric artery origin or overly conservative graft length selection that may lead to unnecessary
extensions. We quantified the degree of path alteration with this endograft and developed an algorithm to predict it.
Methods:Preoperative and postoperative three-dimensional (3D) computed tomographic (CT) scans were evaluated for 50
consecutive patients with Gore Excluder endografts by using 21 anatomic measurements and 6 calculated indices.
Measurements were evaluated as if only 3D lumen centerline measurements were available, rather than complete 3D
computer-aided measurement and “virtual graft” simulation. Tortuosity was quantitated from the renal artery to the
hypogastric origin, using the difference between a straight line and the lumen centerline.
Results: The endograft was deployed successfully in all cases. The graft end points were typically quite close to the
preoperative plan: mean renal artery-to-graft distance was within 2.0  .5 mm, and the limb end point-to-hypogastric
origin differed by an average of only 1.8  1.6 mm. Although accurate in most cases, the actual graft path shortened
1 cm or more relative to the centerline in 11% of limbs. On univariate analysis, determinants of alteration of>1 cm in the
graft deployment path were (1) aortoiliac tortuosity (renal-to-hypogastric artery, P < .002), (2) the degree of planned
graft rotation (73% of cases altered >10 mm were in the rotated position, P < .05), and (3) the insertion side (73% of
alterations>10mmwere ipsilateral to the main device, P< .05). Onmultivariate analysis, the renal-to-hypogastric artery
tortuosity index (RHTI) was significant (P < .004), and device type and rotation approached significance (P < .08). We
developed a classification scheme based on RHTI to predict the risk of alteration of the graft path >1 cm (low risk, 0%;
medium risk, 10%; high risk, 25%) and an algorithm to predict the degree of alteration of the anatomy that reduced the
number of cases shortening >1 cm to zero.
Conclusions: The graft deployment path will be altered significantly in a minority of cases with the Gore Excluder
endograft, but this can cause hypogastric occlusion or other problems. Anatomic shortening is predictable from
morphologic features such as tortuosity, graft insertion side, and rotation. We developed an algorithm based on a
tortuosity index that quantitates the risk and degree of shortening associated with endograft deployment. (J Vasc Surg
2005;41:575-83.)The Gore Excluder endograft (WL Gore & Associates)
has been commercially available since 2002 and has been
successfully placed in a large number of abdominal aortic
aneurysms, encompassing a wide variation in morphol-
ogy.1,2 A unique characteristic of the Excluder is its rapid
deployment mechanism. By pulling a release cord, the
constrained self-expanding endoprosthesis is allowed to
rapidly expand to its designed diameter, typically in 1
second. The standard deployment of the endoprosthesis
includes a “super-stiff” guidewire. As with any device for
endovascular repair, the combined guidewire, endopros-
thesis, and delivery system may straighten tortuous anat-
omy to some degree. This straightening effect can thus
result in the endograft taking a shorter path than planned
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With all devices, there is a tendency for at least partial elastic
recoil of the aortoiliac arteries back to their original shape as
the stiff delivery system is withdrawn. Our early experience
with this particular device, however, suggested that in a
minority of cases the rapid expansion and small delivery
profile of this device might allow distal endograft fixation
with the anatomy in a more straightened configuration
than planned.
Typically, the small amount of straightening that oc-
curs with this phenomenon can be easily predicted with
preoperative planning based on three-dimensional (3D)
computer-aided measurement, planning, and simulation
(3D CAMPS) based on computed tomography (CT) or
magnetic resonance scans.3-5 In our series, length predic-
tion with 3D CAMPS is very accurate and more accurate
than using marker catheter angiography.5 We have found
this is true even if a “road-map” angiogram is performed,
followed by insertion of a stiff guidewire into the marker
catheter in an effort to take the shortening effect into
account. Many centers still use less sophisticated 3D lumen
centerlines alone, CT “angio” only, or marker catheters for
length measurements, however (Fig 1).
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uncommon, it can result in two problems: (1) it can cause
the device end point to end more distally and thus occlude
a hypogastric artery, and (2) it can cause overly conservative
device sizing, causing one to choose a shorter device in an
effort to avoid inadvertent coverage of the hypogastric
artery. The latter compensation, unfortunately, can also
result in unnecessary extensions that may cost $2000 each,
not to mention greater procedure time and the additional
risk and potential durability issues of an unnecessary mod-
ular connection.
No matter what type of preoperative imaging is per-
formed, some element of clinical judgment must always be
applied to account for factors such as tortuosity (Fig 1).
Although our group and others have found 3D CAMPS or
similar technology to be more accurate3-8 than marker
catheter angiography, the prediction of the “virtual graft”
path and especially “centerline-only” methods can still be
improved, especially in tortuous anatomy. Because of ap-
parent differences in devices, this may need to be studied in
a device-specific manner. We studied clinical results with
this endograft for two purposes: (1) to quantify the inci-
dence and severity of graft path alteration with the Excluder
device, and (2) to develop a mathematic algorithm to
predict this alteration and thus to calculate a more optimal
graft length on this basis.
METHODS
We reviewed 50 consecutive endograft placements
(100 graft limbs) in patients who received Gore Excluder
endografts at our institution between January 1999 and
September 2003. The endografts in this study are a sub-
group of 250 endovascular aortic aneurysm repairs during
Fig 1. Comparison of length measurements with three-
illustrating that multiple interpretations of the potential
length from the renal artery to the left hypogastric arte
“virtual graft” technique to account for the actual graft s
is 22 cm if the catheter is unconstrained but is only 14 cthis time period. This study purposely includes devicesplaced during clinical trials with this device and thus in-
cludes the initial “learning curve” for the different investi-
gators using the device at our institution. Data collection
was approved by the institutional review board for human
subjects.
Imaging. The primary preoperative imaging modality
in all patients was spiral CT in conjunction with 3D recon-
struction and Computer-Aided Measurement, Planning,
and Simulation (3D CAMPS) software (Preview,® Medical
Metrix Solutions, formerly Medical Media Systems, West
Lebanon, NH). CT protocols were designed to image from
the celiac artery to the femoral arteries, with good detail of
branch vessels and adequate resolution for high-quality 3D
reconstructions.3,4,9 Contrast injection was at a rate of 3 to
4 mL/s (timed by CT monitoring or timing of a test bolus)
and the iodinated contrast volume was typically 120 mL.
For earlier generation scanners, collimation was typically 3
mm in the visceral aortic segment and 5 mm in the distal
abdomen/pelvis, with a pitch of 1. More recently, collima-
tion was typically 2.5 mm throughout. At all time points,
reformats in the axial, sagittal, and coronal planes were in 2
mm increments, while reformats perpendicular to the vessel
were 1 mm increments.
Clinically, the 3D CAMPS software was used for pa-
tient selection and device sizing, including standard preop-
erative measurements, “virtual graft” simulation to deter-
mine optimal graft rotation, and other key aspects of
preoperative planning.4,5 Intraoperative technique, includ-
ing use of the 3D software for proper C-arm gantry posi-
tioning, has also been described previously.4,5,10 Device
deployment technique was according to the device instruc-
tions for use in all cases.
Study measurements. We used the 3D CAMPS soft-
nsional (3D) and angiographic marker catheter imaging,
graft path are possible. In A, the 3D lumen centerline
17 cm., whereas in B, the 3D user-defined path using
15.8 cm. In C, the angiographic marker catheter length
stiff guidewire is placed within the marker catheter.dime
endo
ry is
ize isware to perform 21 anatomic and graft measurements
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scans. Length measurements were performed as if only
lumen centerline measurements were available, however,
and not by using the “virtual graft” simulation. To main-
tain uniformity, two reviewers adhered to the anatomic
definitions for the measuring protocol. The reviewers’ pre-
operative measurements for the study were compared with
Table I. Measurements and definitions
Measurement
Type of
measurement Notes
Renal to aortic
bifurcation
Centerline
Renal to aortic
bifurcation
Straight line
Renal to graft Centerline
Limb to
hypogastric
Centerline Left and right
Renal to
hypogastric
Centerline Left and right
Renal to
hypogastric
Straight line Left and right
Top of graft to
limb end
Centerline Left and right
Top of graft to
limb end
Straight line Left and right
Aortic bifurcation
to hypogastric
Centerline Left and right
Aortic bifurcation
to hypogastric
Straight line Left and right
Aortic neck angle
(3D)
Angle 3D measurement
Iliac bifurcation
angle (3D)
Angle 3D measurement
Top of graft to 20
mm distal
Centerline
Top of graft to 20
mm distal
Straight line
Renal to
hypogastric
Calculated
index
Centerline/straight
line
Renal to
hypogastric
Calculated
index
Centerline – straight
line
Renal to aortic
bifurcation
Calculated
index
Centerline/straight
line
Renal to aortic
bifurcation
Calculated
index
Centerline – straight
line
Aortic bifurcation
to hypogastric
Calculated
index
Centerline/straight
line
Aortic bifurcation
to hypogastric
Calculated
index
Centerline – straight
line
Aortic bifurcation, Defined by computed tomography (CT) reformat in
which flow divider of aortic bifurcation first appears as a line; Hypogastric
(internal iliac artery), defined by CT reformat in which internal iliac artery
clearly separates from external iliac artery (so it can be identified post-op also
if the hypogastric was covered, intentionally or not); Renal, defined by CT
reformat marking the inferior border of the lowest renal artery. Top of graft,
defined by CT reformat in which the most proximal extent of the main body
graft encompasses 50% or more of the lumen circumference; Limb end,
defined by CT reformat in which the most distal extent of the iliac limb
encompasses 50% or more of the lumen circumference. Start and endpoints
for length measurements are defined as the center of the aorta in the
orthogonal CT reformat that includes the stated anatomic feature. For both
preoperative and postoperative data, the “path length” is defined from
lowest renal artery to hypogastric on each side.prospective 3D virtual graft simulations and clinic or oper-ative notes to confirm that the actual graft placements were
done in accordance with the preoperative plans (all were).
In addition to standard anatomic measurements, we
prospectively formulated six different indices of tortuosity
to evaluate a possible association with graft path alteration,
consistent with proposed standards.11 These indices are
defined in Table I and Fig 2. To account for the potential
variability produced by the structural differences in the
ipsilateral main device and contralateral limbs of the en-
dograft, all graft path measurements were identified as
either ipsilateral (main device) or contralateral (contralat-
eral limb). Because the graft can be purposely rotated to
facilitate cannulation of the contralateral limb, the orienta-
tion and degree of rotation for each limb were recorded in
90-degree increments. The “standard” configuration was
Fig 2. Example of measurements used to evaluate tortuosity.
Shown here are 3D measurements for the renal artery-to-hypogas-
tric artery tortuosity index (RHTI), where RHTI  (lumen cen-
terline length – straight line length) as measured from the center of
the aorta just below the lowest renal artery to the center of the
common iliac artery just proximal to the hypogastric artery origin.
The other tortuosity indices are calculated in similar fashion as
described in Table I.defined as positioning of the contralateral docking limb to
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a “standard” posteroanterior fluoroscopic projection.
The postoperative measurements were performed for
the actual graft path seen on the CT. For both preoperative
and postoperative data, the “path length” was defined from
lowest renal artery to the hypogastric on each side (Table I)
to avoid confounding issues related to distance from the
renal artery to the top of the graft after placement. The
actual centerline path including the endograft, as deter-
mined on CT, was compared with the actual preoperative
lumen centerline (not the virtual graft simulation). It is
important to note that in many cases, the preoperative plan
was designed to take advantage of a graft path shorter than
the centerline path, including a “user defined graft path”4,9
or purposely rotating the endograft away from the “stan-
dard” rotation, or both, to intentionally shorten one limb
or lengthen the opposing limb (Fig 3).5 For the sake of the
study, however, any shortening of the path relative to the
lumen centerline was considered to be “shortening,” even
if it was created intentionally or accounted for in the
preoperative plan.
Statistical analysis. Anatomic measurements were an-
alyzed using Statview, a standard statistical software pack-
age (SAS Institute, Cary, NC). Nominal variables were
compared by 2 or the Fisher exact test. Continuous vari-
ables were analyzed using analysis of variance (ANOVA),
and linear regression was used to evaluate potential corre-
lation between preoperative measurements and graft path
alteration. Multivariate logistic regression analysis was per-
formed to evaluate variables that were significant by univar-
iate analysis.
RESULTS
Technical success and device placement. The en-
dograft was successfully deployed in all 50 patients (100
limbs). Device deployment was generally quite accurate,
with the distance from the renal artery to the top of the
graft on the postoperative CT scan 2.0  .5 mm of the
planned deployment location. One graft was unintention-
ally deployed 14 mm below the renal arteries, resulting in
the only aortic cuff and the only unplanned device exten-
sion in the series. There were 19 planned iliac limb exten-
sions and 16 limbs planned to extend into the external iliac
artery for complete aneurysm exclusion. In those limbs
where the hypogastric was not intentionally covered, the
average final distance between the end of the graft limb and
the hypogastric origin was 1.8  1.6 mm of the planned
position (0.4 1.5 mm if including limbs with extensions).
Inadvertent coverage of hypogastric arteries occurred in
two patients, and in one of the two cases was due to
deployment of the device 14 mm below the renal arteries,
rather than 2 mm as planned. Three of 100 hypogastric
arteries were inadvertently covered, with no sequelae in one
patient and spontaneously resolving claudication in the
patient with bilateral coverage. There were no attachment
site or device junction endoleaks at completion or follow-up.
Anatomic data and univariate analysis. The results
for anatomic measurements are listed in Table II, includingANOVA and linear regression to evaluate potential corre-
lation between anatomic measurements and graft path al-
teration (specifically, shortening of10 mm for ANOVA).
With regard to these patient-specific anatomic variables,
only tortuosity of the native anatomy was significantly
associated with the degree of postoperative path alteration
(Table II). Of the six tortuosity indices, the renal-to-
hypogastric tortuosity indices demonstrated the best corre-
lation with alterations in the graft path, as summarized in
Table III.
The change in the distance from the lowest renal artery
to the hypogastric artery (centerline preoperative – actual
postoperative) averaged 3.2  .7 mm. The actual postop-
erative graft path was 10 mm shorter than the preoperative
centerline path in 11% of limbs. Differences of this degree
appeared to be associated with both the degree of the
planned graft rotation (73% of these cases were in the
rotated position, P  .02, 2) and with the main device
(73% of these cases were ipsilateral to the main device, P
.05). When evaluating these factors in combination, the
limbs associated with both main device and graft rotation
were more likely to have a shorter postoperative path
(mean, 7.2  1.8 mm) than those with characteristics of
main device-standard position (1.5  0.9 mm), contralat-
eral limb-standard position (2.8  0.8 mm), or contralat-
eral limb-rotated (2.6  2.4 mm), P  .03 ANOVA.
It was also uncommon for the actual postoperative graft
path to take a longer route than the preoperative centerline
path, as the actual graft path was only 5 mm longer than the
preoperative centerline in 8% of limbs. Limbs taking a
longer path were also associated with the limb type and
graft rotation, as 75% of these were contralateral limbs and
75% were rotated from standard position (P  .05). Thus,
graft rotation from the standard position appeared to be
associated with altered path in general (shorter or longer),
whereas the main device appeared to be more specifically
associated with a shorter path.
Multivariate analysis. Factors that appeared to be
associated with graft path alteration on univariate analysis
were then input into a multivariate logistic regression
model for graft path alteration of10 mm. In this analysis,
the only significant variable was related to the degree of
tortuosity. The renal-to-hypogastric tortuosity index
(RHTI) was the best of the tortuosity indices (P .004), as
defined in Table I and shown in Fig 2. Combining the
variables for device (main device vs contralateral limb) and
for graft rotation (rotated vs “standard” position) into a
single variable for “limb type and rotation” resulted in a
single variable that approached significance in the multivar-
iate analysis (P  .08), but did not improve the model
statistically.
Categorization of risk-predictive algorithm.
Tortuosity was thus used to assess a potential risk-predic-
tion strategy. The population in this study was subdivided
based on the RHTI calculated as 3D centerline distance –
3D straight-line distance (Fig 2). A simple categorization
method was created, with the limbs grouped into three
categories of risk for an altered graft path: low risk (RHTI
tive t
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risk (RHTI 39 mm). Of the 100 limbs, 25 were consid-
ered low risk, 55 were medium risk, and 20 were high risk.
The risk of a path “shortened” 10 mm or more was low
Fig 3. Virtual graft simulation to demonstrate the poten
device (trunk and ipsilateral limb). Configurations show
standard contralateral position; B, main device inserted v
position; C, main device inserted via left with docking
inserted via left with docking limb rotated 90 degrees, t
simulation, but has different endpoints because of the sid
in each case and illustrates the utility of simulating the
rotation within the anatomy rather than constraining the
preferred in this case, as they allow the device to bend alo
compress the docking limb and collapse it before can
cannulation of the docking limb much more difficult.
configuration and where the device will be deployed relarisk, 0%; medium risk, 10%; and high risk, 25%.RHTI and linear regression data were used to create an
algorithm to predict the degree of graft path alteration
(Table IV). Using the preoperative 3D centerline only, the
graft path length “error” (predicted – actual) was 8.1  2
ffect of endograft rotation and insertion site for the main
A, main device inserted via right with docking limb in
ht with docking limb rotated 90 degrees, to an anterior
in standard contralateral position; D, and main device
anterior position. The device length is the same in each
sertion and rotation. A shorter device should be chosen
ograft insertion side, length, diameter, and amount of
ation rigidly to the centerline. ConfigurationsB orD are
most flexible axis. The configuration shown in A might
ion, and the configuration shown in C would make
e length would be adjusted to account for the chosen
o the renal arteries.tial e
n are
ia rig
limb
o an
e of in
end
simul
ng its
nulat
Devicmm in the high-risk group (the actual path was shorter,
ogastri
he ref
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expected). By applying a corrective algorithm based on
RHTI, the predicted graft position was modified such that
the actual path would end with the distal graft 1.1 2 mm
proximal to the predicted location in the high-risk group,
rather than 8.1 mm distal to the predicted location (Table
IV).
To investigate the potential utility of adding other
factors into the algorithm, a second algorithm was created
to take graft rotation into account. Table IV also displays
the percentage of limbs that would have an actual graft path
length ending 1 cm more distal or 1 cm more proximal than
predicted. As shown, both algorithms reduce the chances
that the graft path will err by 1 cm, and are more
Table II. Anatomic data
Measurement Type of measuremen
Renal to aortic bifurcation Centerline, mm
Renal to aortic bifurcation Straight line, mm
Renal to Graft, pre-op Centerline
Aortic bifurcation to hypogastric Centerline
Aortic bifurcation to hypogastric Straight line
Top of graft to limb end Centerline
Top of graft to limb end Straight line
Renal to hypogastric Centerline
Renal to hypogastric Straight line
Aortic neck angle (3D) Angle, degrees
Top graft to 20 mm distal, pre Straight line
Limb end to hypogastric Centerline
Iliac bifurcation angle (3D) Angle, degrees
Renal to aortic bifurcation Centerline/straight li
Renal to aortic bifurcation Centerline–straight lin
Aortic bifurcation to hypogastric Centerline/straight li
Aortic bifurcation to hypogastric Centerline–straight lin
Renal to hypogastric Centerline/straight li
Renal to hypogastric Centerline–straight lin
Postoperative values
Renal to graft, postop (half circ) Centerline
Change renal-graft (pre-post) Centerline
Change in neck angle postop Angle, degrees
Change in iliac angle postop Angle, degrees
Change in renal to hypogastric Straight line
Change in renal to hypogastric Centerline
*P value for the analysis of variance (ANOVA) statistic, with the nominal va
mm).
†P value for a linear regression of the variable versus Change in renal to hyp
‡Change in renal to hypogastric, centerline is the outcome measure used as t
Table III. Linear regression results for three-dimensional
Measurement Index or ra
Renal to hypogastric Centerline/straig
Renal to hypogastric Centerline – strai
Renal to aortic bifurcation Centerline/straig
Renal to aortic bifurcation Centerline – strai
Aortic bifurcation to hypogastric Centerline/straig
Aortic bifurcation to hypogastric Centerline – strai
Results are for linear regression of the described tortuosity index versus the d
same as other Tables.conservative than the centerline path (ie, having no caseswith a predicted path 1 cm “too long” makes it unlikely that
a hypogastric might be covered inadvertently). Our use of
3D CAMPS with virtual graft simulation appears to have a
similar effect (Table IV), although prospective virtual graft
plans were only available for 40 of 50 cases.
DISCUSSION
In this study, we found that the endograft deployment
path will be altered significantly in a minority of cases with
the Gore Excluder endograft. Although this straighter en-
dograft path infrequently differs by 1 cm from the 3D
lumen centerline path, the effect of a more-distal-than-
planned stent-graft end point can cause hypogastric occlu-
sion in the most extreme cases. Fortunately, it appears that
Mean SE P* P†
125 2 .14 .2
115 2 .7 .9
0.6 .2 .9 .8
61 2 .8 .7
58 1 .4 .2
170 2 .3 .3
144 2 .3 .2
185 2 .15 .2
154 2 .4 .1
21 1 .1 .1
20.6 .5 .7 .3
15 2 .6 .9
78 2 .2 .2
1.1 .01 .001 .01
10 .7 .001 .01
1.1 .01 .14 .02
3.9 .5 .13 .01
1.2 .01 .002 .0001
31 1.2 .002 .0001
2.5 .4 .1 .01
2.0 .5 .25 .1
0.8 .7 .4 .7
0.5 2 .1 .2
1.4 .4 .6 .7
3.2 .7 NA‡ NA
dividing the limbs into groups by degree of shortening (shortening by10
c, centerline length (preoperative centerline – actual postoperative path).
erence for statistical calculations.
osity indices
P R r2
e .0001 .45 .21
ne .0001 .44 .19
e .01 .26 .07
ne .01 .28 .08
e .02 .25 .06
ne .01 .26 .07
of graft path alteration as defined in the text. Measurement definition is thet
ne
e
ne
e
ne
e
riabletortu
tio
ht lin
ght li
ht lin
ght li
ht lin
ght li
egreethis straightening of the anatomy is predictable from ana-
the v
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appears that the shortening affect is much more heavily
influenced by anatomic factors than by device factors.
Although the effect of graft path shortening due to stiff
guidewires and delivery systems may be well known clini-
cally, it has received little attention in the literature. Several
studies have investigated alterations in graft path or aortic
length after endovascular abdominal aortic aneurysm repair
(EVAR), but almost all of these investigate changes over
long time periods caused by aneurysm sac changes.
White et al12 studied acute graft path alterations at the
time of deployment with 39 Vanguard (Boston Scientific)
and 25 AneuRx (Medtronic) devices, suggesting that these
devices tended to have an end point more proximal than
one would expect rather than more distal. Using graduated
marker catheter angiography for length measurements,
they found graft length end point differences of15 mm in
56% of the Vanguard and in 44% of the AneuRx endografts.
Additional extensions were required to correct endoleak
caused by inadequate graft length in 14% of patients.
One potential explanation for the findings of White et
al is the use of marker catheter angiography for preoperative
length measurements. Although standard at the time of
that study and still used in many centers, we have found that
marker catheter angiography is not as accurate as the 3D
CT lumen centerline or more advanced technology like 3D
CAMPS. In prospective comparisons of 3D CAMPS and
marker catheter angiography for EVAR, we found them to
differ by1 cm in 19% of limbs and 3D CAMPS to be more
accurate in each case.3-5 Our initial validation cases also
included AneuRx and Vanguard devices identical to those
cited in the study of White et al.
We have eliminated the need for preoperative marker
catheter angiography since 1996 by using 3D CAMPS,
with excellent results for a wide variety of endografts, in the
largest series using 3D CAMPS to prospectively determine
endograft length and diameter to date.5 With a single
exception using a different system,14 other smaller series
have also confirmed that 3D CAMPS (or similar technol-
Table IV. Prediction algorithm results
Method to Assess Graft Path Length
(results in mm)
Low risk
N  25
Med r
N 
Preop centerline – actual path 1.8  1 2.1 
Algorithm 1, predicted – actual path 1.6  1 1.7 
Algorithm 2, predicted – actual path 0.8  1 2.9 
Centerline to end of virtual graft‡ 6.2  4 16 
Algorithm 1 3D centerline – [(RHTI 0.266) 4]; Algorithm 2 3D c
to hypogastric tortuosity index) is “renal-to-hypogastric, centerline – straig
*ANOVA for the degree of difference in path length for the various metho
†Percentage of patients who would have an actual graft path length1 cm sh
cm longer than predicted (thus the graft endpoint is more proximal than pr
‡Centerline measurements do not account for our clinical use of a user-defin
by rotating the graft, which is accounted for in the final row of the table. Th
the simulated virtual graft end point, greater in the higher-risk groups. Thus
1 cm different than predicted when virtual graft was used.ogy) is equivalent or superior to marker catheter angiogra-phy.6-8,13,15,16 Thus, the discrepancy in endograft path
length issues is more likely imaging-related rather than
device-related in this case.
Despite the accuracy of 3-D CAMPS, we are constantly
seeking improvement or automation, or both, especially for
“exception” cases at the extremes of typical anatomy. Ini-
tially, as we helped develop 3D CAMPS and virtual graft
simulation, we would evaluate both the centerline path and
what we have described as a “user-defined” path when we
thought the endograft might not follow the centerline (Fig
1).3-5 After numerous cases, we found that the “user-
defined path” was usually shorter than the centerline path,
but the differences were small, typically 5 mm. After the
first 100 cases, we performed the “user-defined path”4,5
only for atypical cases with more tortuous anatomy, as it is
somewhat tedious to perform.
Tillich et al17 used 3D imaging to evaluate preoperative
and postoperative stent-graft length in 31 AneuRx and 2
Excluder stent-grafts. They suggested that the stent-graft
path is best predicted by the shortest 3D aortoiliac path
length maintaining at least one iliac radius distance from
the vessel wall, with a mean error of 2.1 mm  4.6 mm.
Their results are similar to the mean value in the present
study using 3D lumen centerline measurements. However,
even a lumen centerline path will be shorter than the actual
graft path in some cases (Table IV), so the routine use of a
“shortest possible” path is not an ideal solution.
Thus, the key is to know when significant straightening
of the anatomy is likely and then to select the endograft
length appropriately. In this regard, awareness of the key
risk factors or a predictive algorithm, or both, should
improve the accuracy of deployment and clinical results. Of
course, the importance of tortuosity is obvious, and some
might believe it is a simple matter to evaluate tortuosity on
CT or angiography. We believe that quantifying the asso-
ciated graft path alteration will be helpful, however.
It is a simple matter to determine that the anatomy is
“tortuous,” but estimating the stent-graft endpoint is not
trivial, especially for device-specific issues. Wolf et al,18
High risk
N  20 P*
Actual ends
1 cm distal†
Actual ends
1 cm prox†
8.1  2 .003 11% 3%
1.1  2 .3 2% 5%
3.4  2 .1 0% 9%
23  2 .01 2% 0%
ine [(RHTI 0.266) 4 (3.4 if graft is rotated)], where RHTI (renal
” as defined previously.
sus risk stratification (low, medium, high).
than predicted (thus the graft endpoint is more distal than predicted) or1
d).
tual graft path simulation or purposely taking advantage of path shortening
demonstrates a significant difference between the centerline end point and
irtual graft simulation can also identify the risk, and only 2% of grafts endedisk
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April 2005582 Whittaker et allonger fluoroscopy time, more contrast, use of extensions,
arterial reconstruction, and endoleak. We had no arterial
reconstructions or type I endoleak, and 16 of 19 extensions
in this study were required because of planned end points in
the external iliac, so we cannot readily compare the two
experiences. Nevertheless, this points out the importance of
tortuosity in terms of case planning and patient selection
for EVAR.
It is also important to note potential risk factors for an
altered graft path that can be controlled by the implanting
physician. Endograft rotation is perhaps the most difficult
of these factors to predict, especially without access to 3D
CAMPS. In some cases, rotation away from the standard
position will shorten the actual graft path, whereas in
others, it will lengthen it (Fig 3). This points out why
simple mathematic algorithms cannot replace the combina-
tion of an accurate representation of the 3D anatomy and
experienced clinical judgment. We frequently plan graft
rotation to purposely shorten the actual graft path, to allow
the device to bend along a more natural axis, or to make
cannulation of the docking limb easier.4,5,10
The trunk-ipsilateral limb deployment system may also
be a risk factor for a straightened graft path due to its
stiffness and length (in comparison with the contralateral
limb). By using 3D CAMPS and virtual graft simulation,
case planning strategy becomes much more obvious (Fig
3). For the actual case plans in this series using 3D CAMPS,
we planned a shorter path than the centerline for the more
tortuous cases (Table IV). This verifies our impression that
virtual graft simulation, which includes simulation of the
endograft diameter, is quite accurate, but incorporating the
data from this study may improve these simulations further.
Finally, the cases with hypogastric coverage in this
series involved less experienced users, and experience
clearly impacts EVAR results in general.19,20 For example,
the main device may be deployed more distally than origi-
nally planned, causing the distal end point to end more
distally than planned. We have found that using 3D
CAMPS to correct the C-arm gantry position for the aortic
“neck” assists greatly in proper device placement immedi-
ately below the renal arteries.10 Gantry angle correction
alone can cause errors of 1 cm in graft deployment and
should be accounted for.4,21 Our results in this series for
device placement relative to the renal arteries are quite
good, in part because of gantry correction. In one case with
hypogastric occlusion in this series, the plan accounted for
shortening, but not adequately, in anatomy that is now
known to be more than two standard deviations from the
mean by tortuosity index. We believe these learning curve
issues can be overcome, or at least improved, with imaging
technology.
One might argue that the solution to graft path alterations
is to use “conservative” device sizing, choosing a shorter
device in an effort to avoid inadvertent coverage of the hypo-
gastric artery. This compensation, unfortunately, can result in
unnecessary extensions that may cost $2,000 each, not to
mention greater procedure time, additional risk, and potential
durability issues of an unnecessary modular connection. Thegoal of EVAR should be to minimize the number of exten-
sions, the inadvertent coverage of a hypogastric artery, and the
incidence of endoleak. In this series, there were no type I
endoleaks, and 28% of patients had extensions, compared with
40% in the most recent Gore Excluder trial.22 This is consis-
tent with findings of our center and others that 3D CAMPS
results in less extensions than marker catheter angiogra-
phy.8,23 The percentage of inadvertent hypogastric coverage
was not reported in the Excluder trial, but the rate in this study
compares favorably to the rate of 3% to 10% in the literature.23
Our multiple-device series also has one of the lowest reported
rates of inadvertent hypogastric coverage at 1.5%.23
Conclusion. The graft deployment path will be al-
tered significantly in a minority of cases with the Gore
Excluder endograft, but anatomic shortening is predict-
able. We developed an algorithm that quantitates the risk
and degree of shortening associated with endograft deploy-
ment, which will need to be validated prospectively on an
independent dataset.
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